Please login to the form below

Not currently logged in
Email:
Password:

ReNeuron

This page shows the latest ReNeuron news and features for those working in and with pharma, biotech and healthcare.

ReNeuron set for recovery after Woodford stake sale

ReNeuron set for recovery after Woodford stake sale

Meanwhile, ReNeuron’s stem cell therapy programmes are progressing on track, says Savin in a recent research note. ... In an update posted this week, ReNeuron notes that the larger PISCES-3 study in the US is proceeding on course.

Latest news

  • ReNeuron aiming to take second stem cell therapy into clinic ReNeuron aiming to take second stem cell therapy into clinic

    UK stem cell specialist ReNeuron has filed for approval to start clinical trials of a treatment for the genetic eye disease retinitis pigmentosa (RP) in the US. ... ReNeuron is already conducting trials of a neural stem cell product called CTX in stroke

  • ReNeuron wins orphan status for stem cell therapy ReNeuron wins orphan status for stem cell therapy

    ReNeuron's investigational stem cell therapy has received orphan status in the EU and US for use in a rare eye disorder. ... ReNeuron's CEO Michael Hunt said the company was “delighted” to receive orphan designation for ReN003, adding that it fitted

  • Government funding brings ReNeuron to Wales Government funding brings ReNeuron to Wales

    Stem cell specialist moves from former base in England. Stem cell specialist ReNeuron will shift its operations from England to Wales on the back of an equity investment and funding by ... ReNeuron posted a loss of £6.3m last year and at the end of

  • ReNeuron and Schepens stem cell patent

    ReNeuron Group has signed a patent and know-how license agreement with Schepens Eye Research Institute. ... our collaboration with ReNeuron under this new agreement, bringing us closer to the day when blindness can be treated with stem cells." .

  • Switched on

    Meanwhile, in the UK, ReNeuron is moving forward with testing a stem cell therapy for stroke (ReN001).

More from news
Approximately 4 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Glythera appoints Dr Mike Owen Glythera appoints Dr Mike Owen

    Owen is also currently a director of Avacata plc, Blink Biomedical SAS, GammDelta Therapeutics, Ossianix Inc, ReNeuron plc and Zealand Pharma A/S.

  • ReNeuron makes shifts and additions to senior team ReNeuron makes shifts and additions to senior team

    for the development of ReNeuron's in-house manufacturing capability when it relocates its operations to South Wales later this year. ... Their skills and experience will be invaluable as ReNeuron continues its transition into a fully fledged clinical

  • ReNeuron appoints new CEO ReNeuron appoints new CEO

    Michael Hunt, who has held the position of CEO since July 2005, will remain on ReNeuron's Board as chief financial officer. ... Bryan Morton, chairman of ReNeuron, commented: “I am delighted to welcome Olav Hellebø to the role of chief executive

  • Simbec appoints ex-ABPI DG as chairman Simbec appoints ex-ABPI DG as chairman

    Earlier this week, ReNeuron stated that the Fund was behind its move from England to Wales, and Sir Chris said that Simbec's appointment of Prof Jones was further evidence for

More from appointments
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies

    Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the ... Image: Olav Hallebo, CEO, ReNeuron. The global stem cell market is

  • How do you define a biotech company?

    ReNeuron, a leading, clinical-stage stem cell business.

  • Blue Latitude Health Blue Latitude Health

    Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies. ... Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics